Melane Sampson, Author at BioTuesdays

Feature

Conavi merger and financing to help ignite widespread adoption of next-generation Novasight Hybrid intravascular imaging platform

Conavi Medical’s reverse merger with Titan Medical (TSX: TMD; OTC: TMDIF), which is expected to close in July 2024, and concurrent financing are anticipated to cultivate an investor network to help fund the expansion of...

April 2, 2024

Feature

BioRestorative Therapies propelling cell-based therapies for lower back pain, Obesity, Type 2 diabetes and more

BioRestorative Therapies (NASDAQ:BRTX) is a fully integrated regenerative medicine company with preclinical and Phase 2 clinical programs focused on conditioning the bodies’ regenerative potential to treat major...

March 5, 2024

Feature

iBio fast-tracking discovery for hard-to-drug targets with precision antibody therapeutics powered by AI and machine learning

iBio (NYSEA:IBO) is developing next-generation biopharmaceuticals leveraging computational biology and 3D-modeling of epitopes enabling the discovery of new antibody treatments for hard-to-target cancers and other...

February 6, 2024

Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...

January 9, 2024

Feature

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Closely-held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...

December 19, 2023

Feature

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

As founder and executive chair of the non-profit Indo-US Organization for Rare Disease (IndoUSrare), Harsha Rajasimha, Ph.D., social entrepreneur, and subject matter expert in bioinformatics, data analysis, and...

December 12, 2023

Feature

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Closely-held Upswing Health, a virtual orthopedic company, is reinventing orthopedic care delivery through its virtual orthopedic musculoskeletal symptom assessment tool and customized pain management program...

November 21, 2023

Feature

Hygieia – leveraging science + research + technology to revolutionize how patients manage insulin dosing

Closely-held Hygieia, a digital therapeutics company for insulin therapy, is reforming how physicians and people with type 2 diabetes manage insulin with its breakthrough proprietary mobile app, d-Nav, which...

October 24, 2023

Feature

EndoGlow – advancing fluorescent-guided surgeries with breakthrough device and technology

Closely-held EndoGlow, a medical device company, is revolutionizing minimally invasive surgery and improving patient outcomes by enhancing visualization through its proprietary Tissue Reveal Technology (TRT), a polymer...

October 10, 2023

Developments

IntelGenx adds Douglas Mental Health University Institute to Montelukast VersaFilm trial sites

IntelGenx (TSXV:IGX; OTCQX:IGXT) plans to add Montreal’s Douglas Mental Health University Institute to its Montelukast VersaFilm Phase 2a clinical trial in patients with mild-to-moderate Alzheimer’s disease (AD). World...

February 14, 2019

Author - Melane Sampson

Conavi merger and financing to help ignite widespread adoption of next-generation Novasight Hybrid intravascular imaging platform

BioRestorative Therapies propelling cell-based therapies for lower back pain, Obesity, Type 2 diabetes and more

iBio fast-tracking discovery for hard-to-drug targets with precision antibody therapeutics powered by AI and machine learning

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Hygieia – leveraging science + research + technology to revolutionize how patients manage insulin dosing

EndoGlow – advancing fluorescent-guided surgeries with breakthrough device and technology

IntelGenx adds Douglas Mental Health University Institute to Montelukast VersaFilm trial sites

General

More